{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:00:38Z","timestamp":1787241638269,"version":"build-2736575974"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011944","name":"School of Public Health, University of California Berkeley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011944","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jaad.2020.04.138","type":"journal-article","created":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T21:04:55Z","timestamp":1588539895000},"page":"370-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"title":["Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation"],"prefix":"10.1016","volume":"84","author":[{"given":"Jacob W.","family":"Glickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celina","family":"Dubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yael","family":"Renert-Yuval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dante","family":"Dahabreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace W.","family":"Kimmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Auyeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeriel D.","family":"Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giselle","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Pavel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2020.04.138_bib1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.det.2012.08.010","article-title":"Alopecia areata update","volume":"31","author":"Alkhalifah","year":"2013","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2020.04.138_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.4065\/70.7.628","article-title":"Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989","volume":"70","author":"Safavi","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jaad.2020.04.138_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib4","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1046\/j.1365-4362.2003.01340.x","article-title":"Alopecia areata: psychiatric comorbidity and adjustment to illness","volume":"42","author":"Ruiz-Doblado","year":"2003","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib5","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1365-4632.2008.03743.x","article-title":"Comorbidity of psychiatric disorders in children and adolescents with alopecia areata in a child and adolescent psychiatry clinical sample","volume":"47","author":"Ghanizadeh","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1365-4362.1994.tb01018.x","article-title":"Alopecia areata and increased prevalence of psychiatric disorders","volume":"33","author":"Koo","year":"1994","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib7","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2018.06.029","article-title":"An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation","volume":"142","author":"Song","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib8","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2133.2007.07943.x","article-title":"Serum chemokine profiles in patients with alopecia areata","volume":"157","author":"Kuwano","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/exd.12918","article-title":"Biomarkers of alopecia areata disease activity and response to corticosteroid treatment","volume":"25","author":"Fuentes-Duculan","year":"2016","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib10","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jaci.2015.06.032","article-title":"Alopecia areata profiling shows TH1, TH2, and IL-23 cytokine activation without parallel TH17\/TH22 skewing","volume":"136","author":"Suarez-Farinas","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib11","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1007\/s12325-017-0542-7","article-title":"The changing landscape of alopecia areata: the therapeutic paradigm","volume":"34","author":"Renert-Yuval","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jaad.2020.04.138_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/jamadermatol.2013.3049","article-title":"Autoimmune, atopic, and mental health comorbid conditions associated with alopecia areata in the United States","volume":"149","author":"Huang","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib13","first-page":"130","article-title":"Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease-associated psychological morbidity","volume":"182","author":"Bain","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib14","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1038\/sj.jid.5700915","article-title":"Loss-of-function mutations in the filaggrin gene and alopecia areata: strong risk factor for a severe course of disease in patients comorbid for atopic disease","volume":"127","author":"Betz","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2020.04.138_bib15","first-page":"1323","article-title":"Alopecia areata is associated with atopic diathesis; results from a population-based study of 51,561 patients","volume":"8","author":"Kridin","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib16","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/jid.2012.129","article-title":"Follow-up study of the first genome-wide association scan in alopecia areata: IL13 and KIAA0350 as susceptibility loci supported with genome-wide significance","volume":"132","author":"Jagielska","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib17","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1046\/j.1087-0024.2003.00802.x","article-title":"Alopecia areata: autoimmunity\u2014the evidence is compelling","volume":"8","author":"Kalish","year":"2003","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2020.04.138_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jaci.2015.11.001","article-title":"Extensive alopecia areata is reversed by IL-12\/IL-23p40 cytokine antagonism","volume":"137","author":"Guttman-Yassky","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/all.13346","article-title":"Alopecia areata is characterized by expansion of circulating Th2\/Tc2\/Th22, within the skin-homing and systemic T-cell populations","volume":"73","author":"Czarnowicki","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaad.2020.04.138_bib20","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1038\/s41598-017-09207-z","article-title":"The atopic dermatitis blood signature is characterized by increases in inflammatory and cardiovascular risk proteins","volume":"7","author":"Brunner","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaad.2020.04.138_bib21","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jaad.2019.10.039","article-title":"The proteomic skin profile of moderate-to-severe atopic dermatitis patients shows an inflammatory signature","volume":"82","author":"Pavel","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaad.2019.04.036","article-title":"The blood proteomic signature of early-onset pediatric atopic dermatitis shows systemic inflammation and is distinct from adult long-standing disease","volume":"81","author":"Brunner","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.anai.2019.10.013","article-title":"Increased cardiovascular and atherosclerosis markers in blood of older patients with atopic dermatitis","volume":"124","author":"He","year":"2020","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2003.09.032","article-title":"Alopecia areata investigational assessment guidelines\u2014part II. National Alopecia Areata Foundation","volume":"51","author":"Olsen","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.2007.08112.x","article-title":"Practical issues on interpretation of scoring atopic dermatitis: the SCORAD index, objective SCORAD and the three-item severity score","volume":"157","author":"Oranje","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib26","doi-asserted-by":"crossref","first-page":"ii65","DOI":"10.1136\/ard.2004.031237","article-title":"Psoriasis assessment tools in clinical trials","volume":"64","author":"Feldman","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaad.2020.04.138_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-4632.2007.03193.x","article-title":"Alopecia areata","volume":"46","author":"Wasserman","year":"2007","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.atherosclerosis.2015.07.023","article-title":"Use of a proximity extension assay proteomics chip to discover new biomarkers for human atherosclerosis","volume":"242","author":"Lind","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaad.2020.04.138_bib29","doi-asserted-by":"crossref","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","article-title":"Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability","volume":"9","author":"Assarsson","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.jaad.2020.04.138_bib30","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bjd.17932","article-title":"The oral JAK\/SYK inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate-to-severe atopic dermatitis: results from a randomised, double-blind, placebo-controlled study","volume":"181","author":"Bissonnette","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.jaci.2019.07.013","article-title":"Oral Janus kinase\/SYK inhibition (ASN002) suppresses inflammation and improves epidermal barrier markers in patients with atopic dermatitis","volume":"144","author":"Pavel","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2202\/1544-6115.1027","article-title":"Linear models and empirical bayes methods for assessing differential expression in microarray experiments","volume":"3","author":"Smyth","year":"2004","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1016\/j.jaad.2020.04.138_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jaad.2020.04.138_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.leukres.2016.09.019","article-title":"Plasma proteomics in CML patients before and after initiation of tyrosine kinase inhibitor therapy reveals induced Th1 immunity and loss of angiogenic stimuli","volume":"50","author":"S\u00f6derlund","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.jaad.2020.04.138_bib35","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jid.2016.09.037","article-title":"An integrated model of atopic dermatitis biomarkers highlights the systemic nature of the disease","volume":"137","author":"Ungar","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib36","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hc3901.096721","article-title":"Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability","volume":"104","author":"Mallat","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2020.04.138_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jjcc.2008.12.007","article-title":"Inflammatory biomarkers in coronary artery disease","volume":"53","author":"Zakynthinos","year":"2009","journal-title":"J Cardiol"},{"key":"10.1016\/j.jaad.2020.04.138_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20011022","article-title":"Expression of interleukin (IL)-18 and functional IL-18 receptor on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for atherogenesis","volume":"195","author":"Gerdes","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaad.2020.04.138_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib40","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2020.01.005","article-title":"Comparing cutaneous molecular improvement with different treatments in atopic dermatitis patients","volume":"145","author":"Glickman","year":"2020","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib41","doi-asserted-by":"crossref","first-page":"41483","DOI":"10.1038\/srep41483","article-title":"Differentially expressed genes and canonical pathway expression in human atherosclerotic plaques\u2014Tampere Vascular Study","volume":"7","author":"Sulkava","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.jaad.2020.04.138_bib42","doi-asserted-by":"crossref","first-page":"110","DOI":"10.4172\/2155-9899.1000110","article-title":"Th2 cytokines and atopic dermatitis","volume":"2","author":"Brandt","year":"2011","journal-title":"J Clin Cell Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib43","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00403-004-0455-6","article-title":"Relative importance of IL-4 and IL-13 in lesional skin of atopic dermatitis","volume":"295","author":"Tazawa","year":"2004","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2020.04.138_bib44","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12920-015-0133-x","article-title":"Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways","volume":"8","author":"Ewald","year":"2015","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.jaad.2020.04.138_bib45","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.anai.2018.08.024","article-title":"Atopic dermatitis in African American patients is TH2\/TH22-skewed with TH1\/TH17 attenuation","volume":"122","author":"Sanyal","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s10930-012-9431-8","article-title":"Highly upregulated expression of CD36 and MSR1 in circulating monocytes of patients with acute coronary syndromes","volume":"31","author":"Piechota","year":"2012","journal-title":"Protein J"},{"key":"10.1016\/j.jaad.2020.04.138_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2018.02.002","article-title":"Evolving targets for the treatment of atherosclerosis","volume":"187","author":"Solanki","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jaad.2020.04.138_bib48","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.2174\/1381612820666140522115801","article-title":"Impact of MCP-1 in atherosclerosis","volume":"20","author":"Lin","year":"2014","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaad.2020.04.138_bib49","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.3389\/fimmu.2018.03127","article-title":"Macrophage foam cell-targeting immunization attenuates atherosclerosis","volume":"9","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib50","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1538-7836.2006.01949.x","article-title":"von Willebrand factor, endothelial dysfunction, and cardiovascular disease","volume":"4","author":"Vischer","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jaad.2020.04.138_bib51","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3389\/fimmu.2018.00744","article-title":"CLEC10A is a specific marker for human CD1c+ dendritic cells and enhances their toll-like receptor 7\/8-induced cytokine secretion","volume":"9","author":"Heger","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib52","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ygeno.2011.08.009","article-title":"Integration of genome-wide transcriptional and genetic profiles provides insights into disease development and clinical heterogeneity in alopecia areata","volume":"98","author":"Coda","year":"2011","journal-title":"Genomics"},{"key":"10.1016\/j.jaad.2020.04.138_bib53","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/j.1365-2141.2012.09218.x","article-title":"Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, T NFSF14 (LIGHT), in sickle cell disease","volume":"158","author":"Garrido","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaad.2020.04.138_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0064729","article-title":"Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes","volume":"8","author":"Menzaghi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jaad.2020.04.138_bib55","first-page":"1265","article-title":"MicroRNA-210 as a novel blood biomarker in acute cerebral ischemia","volume":"3","author":"Zeng","year":"2011","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.1016\/j.jaad.2020.04.138_bib56","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.thromres.2014.06.025","article-title":"Blood genomic profiling in extracranial-and intracranial atherosclerosis in ischemic stroke patients","volume":"134","author":"Lee","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaad.2020.04.138_bib57","first-page":"100370","article-title":"Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction","volume":"24","author":"Schroder","year":"2019","journal-title":"Int J Cardiol Heart Vasc"},{"key":"10.1016\/j.jaad.2020.04.138_bib58","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"Brennan","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.138_bib59","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7754\/Clin.Lab.2013.121245","article-title":"Relationship between serum oncostatin M levels and degree of coronary stenosis in patients with coronary artery disease","volume":"60","author":"Li","year":"2014","journal-title":"Clin Lab"},{"key":"10.1016\/j.jaad.2020.04.138_bib60","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2217\/fca-2016-0063","article-title":"Elevation of plasma oncostatin M in heart failure","volume":"13","author":"Gruson","year":"2017","journal-title":"Future Cardiol"},{"key":"10.1016\/j.jaad.2020.04.138_bib61","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/sj.tpj.6500067","article-title":"Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling","volume":"1","author":"Oestreicher","year":"2001","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.jaad.2020.04.138_bib62","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1038\/jid.2012.184","article-title":"Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis","volume":"132","author":"Su\u00e1rez-Farinas","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib63","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in subjects with psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib64","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/jid.2014.196","article-title":"Molecular characterization of human skin response to diphencyprone at peak and resolution phases: therapeutic insights","volume":"134","author":"Gulati","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib65","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00296-016-3487-2","article-title":"Updates on cardiovascular comorbidities associated with psoriatic diseases: epidemiology and mechanisms","volume":"37","author":"Yim","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jaad.2020.04.138_bib66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.amjmed.2013.08.013","article-title":"Cardiovascular risk and psoriasis: beyond the traditional risk factors","volume":"127","author":"Coumbe","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2020.04.138_bib67","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjmed.2014.08.008","article-title":"Accumulating evidence for the association and shared pathogenic mechanisms between psoriasis and cardiovascular-related comorbidities","volume":"127","author":"Shlyankevich","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2020.04.138_bib68","doi-asserted-by":"crossref","first-page":"776","DOI":"10.2340\/00015555-2964","article-title":"Alopecia areata is associated with increased expression of heart disease biomarker cardiac troponin I","volume":"98","author":"Wang","year":"2018","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2020.04.138_bib69","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00403-018-1853-5","article-title":"Efficacy and safety of secukinumab treatment in adults with extensive alopecia areata","volume":"310","author":"Guttman-Yassky","year":"2018","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.jaad.2020.04.138_bib70","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.jaci.2014.03.003","article-title":"Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology","volume":"133","author":"Khattri","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib71","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1056\/NEJMoa1314768","article-title":"Dupilumab treatment in adults with moderate-to-severe atopic dermatitis","volume":"371","author":"Beck","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.138_bib72","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.jaci.2014.10.013","article-title":"Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis","volume":"134","author":"Hamilton","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1242\/dmm.009092","article-title":"Putting together the psoriasis puzzle: an update on developing targeted therapies","volume":"5","author":"Johnson-Huang","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.jaad.2020.04.138_bib74","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(99)70518-X","article-title":"IL-18: a TH1-inducing, proinflammatory cytokine and new member of the IL-1 family","volume":"103","author":"Dinarello","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib75","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/nm.3890","article-title":"Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter","volume":"21","author":"Wang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jaad.2020.04.138_bib76","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.atherosclerosis.2008.07.015","article-title":"The association between peptidoglycan recognition protein-1 and coronary and peripheral atherosclerosis: observations from the Dallas Heart Study","volume":"203","author":"Rohatgi","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jaad.2020.04.138_bib77","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00018-012-1194-z","article-title":"LOX-1 in atherosclerosis: biological functions and pharmacological modifiers","volume":"70","author":"Xu","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.jaad.2020.04.138_bib78","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/nyas.13984","article-title":"Targeting LOX-1 in atherosclerosis and vasculopathy: current knowledge and future perspectives","volume":"1443","author":"Tian","year":"2019","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaad.2020.04.138_bib79","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1161\/01.CIR.99.24.3110","article-title":"Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions","volume":"99","author":"Kataoka","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2020.04.138_bib80","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1126\/science.1106830","article-title":"Myeloperoxidase, a leukocyte-derived vascular NO oxidase","volume":"296","author":"Eiserich","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.jaad.2020.04.138_bib81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1042\/CS20100366","article-title":"Proteinase 3 and prognosis of patients with acute myocardial infarction","volume":"120","author":"Ng","year":"2011","journal-title":"Clin Sci"},{"key":"10.1016\/j.jaad.2020.04.138_bib82","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.5551\/jat1994.1.Supplemment1_S10","article-title":"Local expression of inflammatory cytokines in human atherosclerotic plaques","volume":"1","author":"Wilcox","year":"1994","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jaad.2020.04.138_bib83","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1074\/jbc.275.8.5466","article-title":"Human vascular smooth muscle cells possess functional CCR5","volume":"275","author":"Schecter","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaad.2020.04.138_bib84","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/j.1476-5381.2010.01147.x","article-title":"Chemokine receptor CCR5: from AIDS to atherosclerosis","volume":"162","author":"Jones","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaad.2020.04.138_bib85","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12933-016-0439-9","article-title":"Emerging role of chemokine CC motif ligand 4 related mechanisms in diabetes mellitus and cardiovascular disease: friends or foes?","volume":"15","author":"Chang","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jaad.2020.04.138_bib86","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00005344-200109000-00008","article-title":"Angiotensin AT1 receptor antagonist irbesartan decreases lesion size, chemokine expression, and macrophage accumulation in apolipoprotein E-deficient mice","volume":"38","author":"Dol","year":"2001","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.jaad.2020.04.138_bib87","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.yjmcc.2008.06.003","article-title":"CCL3 (MIP-1\u03b1) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events","volume":"45","author":"de Jager","year":"2008","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jaad.2020.04.138_bib88","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1161\/01.CIR.97.12.1136","article-title":"Elevated circulating levels of CC chemokines in patients with congestive heart failure","volume":"97","author":"Aukrust","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jaad.2020.04.138_bib89","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1042\/CS20100151","article-title":"Association of putative functional variants in the PLAU gene and the PLAUR gene with myocardial infarction","volume":"119","author":"Xu","year":"2010","journal-title":"Clin Sci"},{"key":"10.1016\/j.jaad.2020.04.138_bib90","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.clindermatol.2013.11.007","article-title":"Atopic dermatitis as a systemic disease","volume":"32","author":"Darlenski","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib91","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/exd.13336","article-title":"Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment","volume":"27","author":"Guttman-Yassky","year":"2018","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaad.2020.04.138_bib92","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.jaci.2017.12.991","article-title":"Serum biomarker profiles suggest that atopic dermatitis is a systemic disease","volume":"141","author":"Thijs","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib93","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"375","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2020.04.138_bib94","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1161\/ATVBAHA.116.307225","article-title":"local production of fatty acid-binding protein 4 in epicardial\/perivascular fat and macrophages is linked to coronary atherosclerosis","volume":"36","author":"Furuhashi","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jaad.2020.04.138_bib95","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cca.2009.02.013","article-title":"Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome","volume":"403","author":"Goncalves","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.jaad.2020.04.138_bib96","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2362.2000.00607.x","article-title":"Association of serum sialic acid and MMP-9 with lipids and inflammatory markers","volume":"30","author":"Kalela","year":"2000","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jaad.2020.04.138_bib97","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/108155890305100517","article-title":"Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation","volume":"51","author":"Ferroni","year":"2003","journal-title":"J Investig Med"},{"key":"10.1016\/j.jaad.2020.04.138_bib98","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ahj.2014.11.015","article-title":"Genetic markers of repolarization and arrhythmic events after acute coronary syndromes","volume":"169","author":"Earle","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jaad.2020.04.138_bib99","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.jaci.2019.08.014","article-title":"IL-12\/IL-23 neutralization is ineffective for alopecia areata in mice and humans","volume":"144","author":"Ortolan","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2020.04.138_bib100","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaad.2016.02.1234","article-title":"Cardiovascular risk in patients with alopecia areata (AA): a propensity-matched retrospective analysis","volume":"75","author":"Huang","year":"2016","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220307593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220307593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:58:57Z","timestamp":1759273137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220307593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0190962220307593"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.138","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cross-sectional study of blood biomarkers of patients with moderate to severe alopecia areata reveals systemic immune and cardiovascular biomarker dysregulation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.04.138","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}